Literature DB >> 27874224

Multiple transporters are involved in natamycin efflux in Streptomyces chattanoogensis L10.

Tan-Jun Wang1, Yi-Ming Shan1, Han Li1, Wei-Wang Dou1, Xin-Hang Jiang2, Xu-Ming Mao1,3, Shui-Ping Liu2, Wen-Jun Guan1,3, Yong-Quan Li1,3.   

Abstract

Antibiotic-producing microorganisms have evolved several self-resistance mechanisms to prevent auto-toxicity. Overexpression of specific transporters to improve the efflux of toxic antibiotics has been found one of the most important and intrinsic resistance strategies used by many Streptomyces strains. In this work, two ATP-binding cassette (ABC) transporter-encoding genes located in the natamycin biosynthetic gene cluster, scnA and scnB, were identified as the primary exporter genes for natamycin efflux in Streptomyces chattanoogensis L10. Two other transporters located outside the cluster, a major facilitator superfamily transporter Mfs1 and an ABC transporter NepI/II were found to play a complementary role in natamycin efflux. ScnA/ScnB and Mfs1 also participate in exporting the immediate precursor of natamycin, 4,5-de-epoxynatamycin, which is more toxic to S. chattanoogensis L10 than natamycin. As the major complementary exporter for natamycin efflux, Mfs1 is up-regulated in response to intracellular accumulation of natamycin and 4,5-de-epoxynatamycin, suggesting a key role in the stress response for self-resistance. This article discusses a novel antibiotic-related efflux and response system in Streptomyces, as well as a self-resistance mechanism in antibiotic-producing strains.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27874224     DOI: 10.1111/mmi.13583

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

1.  Activation of anthrachamycin biosynthesis in Streptomyces chattanoogensis L10 by site-directed mutagenesis of rpoB.

Authors:  Zi-Yue Li; Qing-Ting Bu; Jue Wang; Yu Liu; Xin-Ai Chen; Xu-Ming Mao; Yong-Quan Li
Journal:  J Zhejiang Univ Sci B       Date:  2019 Dec.       Impact factor: 3.066

Review 2.  Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

3.  Efflux identification and engineering for ansamitocin P-3 production in Actinosynnema pretiosum.

Authors:  Xinran Wang; Jianhua Wei; Yifan Xiao; Shuhui Luan; Xinjuan Ning; Linquan Bai
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

4.  Involvement of the SCO3366 efflux pump from S. coelicolor in rifampicin resistance and its regulation by a TetR regulator.

Authors:  Ankita Nag; Sarika Mehra
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-23       Impact factor: 4.813

5.  Comparative Transcriptome-Based Mining of Genes Involved in the Export of Polyether Antibiotics for Titer Improvement.

Authors:  Xian Liu; Yuanting Wu; Xiaojie Zhang; Qianjin Kang; Yusi Yan; Linquan Bai
Journal:  Antibiotics (Basel)       Date:  2022-04-29

6.  TetR-Type Regulator SLCG_2919 Is a Negative Regulator of Lincomycin Biosynthesis in Streptomyces lincolnensis.

Authors:  Yurong Xu; Meilan Ke; Jie Li; Yaqian Tang; Nian Wang; Guoqing Tan; Yansheng Wang; Ruihua Liu; Linquan Bai; Lixin Zhang; Hang Wu; Buchang Zhang
Journal:  Appl Environ Microbiol       Date:  2018-12-13       Impact factor: 4.792

7.  Enhanced Triacylglycerol Metabolism Contributes to Efficient Oil Utilization and High-Level Production of Salinomycin in Streptomyces albus ZD11.

Authors:  Han Li; Jiaxiu Wei; Jianxin Dong; Yudong Li; Yongquan Li; Yinghu Chen; Wenjun Guan
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

8.  Mining and engineering exporters for titer improvement of macrolide biopesticides in Streptomyces.

Authors:  Liyang Chu; Shanshan Li; Zhuoxu Dong; Yanyan Zhang; Pinjiao Jin; Lan Ye; Xiangjing Wang; Wensheng Xiang
Journal:  Microb Biotechnol       Date:  2021-08-26       Impact factor: 5.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.